Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3261361000168119 | Irbesartan HCTZ 300/12.5 (AGH) (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3261371000168113 | Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | Is a | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | has TPUU | Irbesartan HCTZ 300/12.5 (AGH) tablet | true | Inferred relationship | Some | 1 | |
| Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | has TP | Irbesartan HCTZ 300/12.5 (AGH) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan HCTZ 300/12.5 (AGH) tablet, 30, blister pack | Is a | True | Irbesartan HCTZ 300/12.5 (AGH) tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR